330 related articles for article (PubMed ID: 11063610)
1. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH
J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610
[TBL] [Abstract][Full Text] [Related]
2. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
[TBL] [Abstract][Full Text] [Related]
3. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
Aronov AM; Verlinde CL; Hol WG; Gelb MH
J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
[TBL] [Abstract][Full Text] [Related]
5. A bisubstrate analog induces unexpected conformational changes in phosphoglycerate kinase from Trypanosoma brucei.
Bernstein BE; Williams DM; Bressi JC; Kuhn P; Gelb MH; Blackburn GM; Hol WG
J Mol Biol; 1998 Jun; 279(5):1137-48. PubMed ID: 9642090
[TBL] [Abstract][Full Text] [Related]
6. The rational design of trypanocidal drugs: selective inhibition of the glyceraldehyde-3-phosphate dehydrogenase in Trypanosomatidae.
Callens M; Hannaert V
Ann Trop Med Parasitol; 1995 Dec; 89 Suppl 1():23-30. PubMed ID: 8745924
[TBL] [Abstract][Full Text] [Related]
7. Molecular Docking, QSAR and Microscopic Studies of Anti-trypanosomal Compounds from the Pathogen Box.
Ogunleye AJ; Olaolu OS; Ibrahim NB; James AA
Curr Comput Aided Drug Des; 2021; 17(3):378-386. PubMed ID: 32703140
[TBL] [Abstract][Full Text] [Related]
8. Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism.
Bernstein BE; Hol WG
Biochemistry; 1998 Mar; 37(13):4429-36. PubMed ID: 9521762
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of analogs of 2'-deoxy-2'-(3-methoxybenzamido)adenosine, a selective inhibitor of trypanosomal glycosomal glyceraldehyde-3-phosphate dehydrogenase.
Van Calenbergh S; Verlinde CL; Soenens J; De Bruyn A; Callens M; Blaton NM; Peeters OM; Rozenski J; Hol WG; Herdewijn P
J Med Chem; 1995 Sep; 38(19):3838-49. PubMed ID: 7562915
[TBL] [Abstract][Full Text] [Related]
10. 2,N6-disubstituted adenosine analogs with antitrypanosomal and antimalarial activities.
Rodenko B; van der Burg AM; Wanner MJ; Kaiser M; Brun R; Gould M; de Koning HP; Koomen GJ
Antimicrob Agents Chemother; 2007 Nov; 51(11):3796-802. PubMed ID: 17698622
[TBL] [Abstract][Full Text] [Related]
11. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
[TBL] [Abstract][Full Text] [Related]
12. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity.
Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML
Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis.
Dardonville C; Rinaldi E; Hanau S; Barrett MP; Brun R; Gilbert IH
Bioorg Med Chem; 2003 Jul; 11(14):3205-14. PubMed ID: 12818683
[TBL] [Abstract][Full Text] [Related]
14. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG
J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162
[TBL] [Abstract][Full Text] [Related]
15. Modified berberine and protoberberines from Enantia chlorantha as potential inhibitors of Trypanosoma brucei.
Nyasse B; Nkwengoua E; Sondengam B; Denier C; Willson M
Pharmazie; 2002 Jun; 57(6):358-61. PubMed ID: 12116870
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of Trypanosoma brucei GAPDH by 1,3-bisphospho-D-glyceric acid (1,3-diPG) analogues.
Ladame S; Bardet M; Périé J; Willson M
Bioorg Med Chem; 2001 Mar; 9(3):773-83. PubMed ID: 11310612
[TBL] [Abstract][Full Text] [Related]
17. Characterization of 2,4-Diamino-6-oxo-1,6-dihydropyrimidin-5-yl Ureido Based Inhibitors of Trypanosoma brucei FolD and Testing for Antiparasitic Activity.
Eadsforth TC; Pinto A; Luciani R; Tamborini L; Cullia G; De Micheli C; Marinelli L; Cosconati S; Novellino E; Lo Presti L; Cordeiro da Silva A; Conti P; Hunter WN; Costi MP
J Med Chem; 2015 Oct; 58(20):7938-48. PubMed ID: 26322631
[TBL] [Abstract][Full Text] [Related]
18. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase.
Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ
Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225
[TBL] [Abstract][Full Text] [Related]
19. Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.
Patterson S; Alphey MS; Jones DC; Shanks EJ; Street IP; Frearson JA; Wyatt PG; Gilbert IH; Fairlamb AH
J Med Chem; 2011 Oct; 54(19):6514-30. PubMed ID: 21851087
[TBL] [Abstract][Full Text] [Related]
20. Aryl ureas represent a new class of anti-trypanosomal agents.
Du X; Hansell E; Engel JC; Caffrey CR; Cohen FE; McKerrow JH
Chem Biol; 2000 Sep; 7(9):733-42. PubMed ID: 10980453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
